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Abstract
Objective: STAT4 and IL23R loci represent common susceptibility genetic factors in autoimmunity. We decided to
investigate for the first time the possible role of different STAT4/IL23R autoimmune disease-associated
polymorphisms on the susceptibility to develop non-anterior uveitis and its main clinical phenotypes.
Methods: Four functional polymorphisms (rs3821236, rs7574865, rs7574070, and rs897200) located within STAT4
gene as well as three independent polymorphisms (rs7517847, rs11209026, and rs1495965) located within IL23R
were genotyped using TaqMan® allelic discrimination in a total of 206 patients with non-anterior uveitis and 1553
healthy controls from Spain.
Results: No statistically significant differences were found when allele and genotype distributions were compared
between non-anterior uveitis patients and controls for any STAT4 (rs3821236: P=0.39, OR=1.12, CI 95%=0.87-1.43;
rs7574865: P=0.59 OR=1.07, CI 95%=0.84-1.37; rs7574070: P=0.26, OR=0.89, CI 95%=0.72-1.10; rs897200:
P=0.22, OR=0.88, CI 95%=0.71-1.08;) or IL23R polymorphisms (rs7517847: P=0.49, OR=1.08, CI 95%=0.87-1.33;
rs11209026: P=0.26, OR=0.78, CI 95%=0.51-1.21; rs1495965: P=0.51, OR=0.93, CI 95%=0.76-1.15).
Conclusion: Our results do not support a relevant role, similar to that described for other autoimmune diseases, of
IL23R and STAT4 polymorphisms in the non-anterior uveitis genetic predisposition. Further studies are needed to
discard a possible weak effect of the studied variant.
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Introduction
Uveitis can be defined as any inflammation affecting the
uveal tract, the middle vascular layer of the eye, although in the
clinical practice this term includes any intraocular inflammatory
process [1]. The prevalence of uveitis is estimated at 38 cases
per 100,000 people, although it depends on the geographic
area [1]. This condition is considered a major source of visual
impairment as well as an important socio-economic problem,
being the fourth cause of blindness on the worldwide [2]. There
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are different forms of uveitis, including either uveitis triggered
by a wide range of exogenous (infectious and traumatism) or
endogenous agents (non-infectious uveitis related with
inflammatory or autoimmune processes) [3]. In addition, uveitis
patients are frequently classified according to the anatomical
location of the inflammation into anterior uveitis (AU), the most
common form which represents 60% of cases, intermediate
uveitis (IU) (5-13%), posterior uveitis (PU) (15%) and
panuveitis or also called diffuse uveitis (PAN) (20%) [4].
Endogenous uveitis is an inflammatory response triggered by
certain environmental factors in individuals with a particular
genetic component and it is mainly mediated by immune
system driven for a loss of tolerance against self antigens [3].
So far, certain HLA alleles have been strongly associated with
the uveitis predisposition [5,6,7,8]. However, the effect of these
alleles just explains a small part of the uveitis heritability and
different studies have recently highlighted the implication of
non-HLA genetic factors in the susceptibility to this condition
[9,10,11].
There is a well established knowledge that most autoimmune
diseases share a certain percentage of their genetic
component, showing that some pathologies may be influenced
by common pathways [12,13]. Genes encoding signal
transducer and activator of transcription 4 (STAT4) and
interleukin 23 receptor (IL23R) belong to the well established
group of risk factors shared by different conditions that
influence the breakdown of self-tolerance [13]. STAT4 and
IL23R are strongly involved in the control of the immune
system through of the development and perpetuation of Th17
immune responses [14], which display a dominant role in
autoimmunity-associated inflammation [15].
Different studies have identified IL23R as a susceptibility
factor associated to multiple inflammatory conditions
[16,17,18]. In these studies several independent signals
located within IL23R locus were suggested; however, only the
R381Q (rs11209026) polymorphism, whose minor allele plays
a protective role for several autoimmune disease, appear to
have a functional involvement [19,20]. Additionally, the
rs1495965 polymorphism has been reported as the stronger
IL23R association with Behçet’s disease (BD), a systemic
autoimmune disease involving uveitis, in a previous combined
meta-analysis of two genome-wide association studies
(GWASs) [21,22]. On the other hand, STAT4 has been also
identified as another shared susceptibility locus [23,24].
Interestingly, the presence of two STAT4 independent
functional genetic variants associated with systemic lupus
erythematosus (SLE), both affecting the STAT4 levels, has
been recently evidenced by fine mapping [25]. Furthermore,
two functional polymorphisms located at STAT4 gene have
been recently implicated in BD susceptibility by GWASs
[26,27].
Recent data have suggested that autoimmune uveitis also
seems to share common genetic factors with other
autoimmune disorders although these remain unknown yet
[28]. Taking into account all of the above, we herein aimed to
investigate whether the STAT4 and IL23R autoimmune
disease-associated polymorphisms are involved in the genetic
predisposition to autoimmune uveitis.
Methods
Study population
Ethics statement.  A subject’s written consent was obtained
according to the declaration of Helsinki, and the design of the
work was approved by the Ethics Committee of Granada
(Spain). The Ethics Committees of the Hospital de León
(León), Hospital Universitario Príncipe de Asturias (Alcalá de
Henares), Hospital de Cruces (Bilbao), Hospital Clinic
(Barcelona), Hospital Clínico San Carlos (Madrid), Hospital
Marqués de Valdecilla (Santander), Hospital Universitario La
Fe (Valencia), Hospital Clínico San Cecilio (Granada) and
Hospital Carlos Haya (Málaga) also approved the study.
A total of 206 patients with endogenous non anterior uveitis,
excluding the uveitis forms associated with systemic immune-
mediated diseases except the Vogt-Koyanagi-Harada
syndrome, and 1553 ethnically matched healthy controls, all of
them of Caucasian origin, were included in the present study.
The main clinical and demographic characteristics of uveitis
patients included in the present study are described in Table 1.
The intraocular inflammation seen in patients included
intermediate uveitis (24.8%), posterior uveitis (50.0%), and
panuveitis (25.2%).
Genotyping
Genomic DNA was extracted from peripheral white blood
cells and saliva following standard procedures. The single-
nucleotide polymorphisms (SNPs) were genotyped using pre-
designed TaqMan® allelic discrimination assays in a 7900HT
Real-Time polymerase chain reaction (PCR) System from
Applied Biosystems under conditions recommended by the
manufacturer (Foster City, CA, USA).
Since the aim of this study was to investigate whether
different STAT4/IL23R autoimmune disease-associated
polymorphisms were also implicated in the susceptibility to
develop non-anterior uveitis, the IL23R and STAT4
polymorphisms most robustly associated with autoimmunity
were selected. Following this criterion, we studied the IL23R
rs11209026 genetic variant, encoding the functional amino-acid
change Arg381Gln [16,17,18,19,20], and two independent
Table 1. Clinical and demographic features of uveitis
patients.
General characteristics of uveitis patients All patients n=206
Female (%) 126 (61.2)
Age (mean ± SD) 47.3 ± 16.9
Intermediate Uveitis (%) 51 (24.8)
Posterior Uveitis (%) 103 (50.0)
Panuveitis (%) 52 (25.2)
Bilateral affection (%) 153 (74.3)
Vitritis (%) 135 (65.5)
Macular edema (%) 92 (44.7)
Retinal vasculitis (%) 87 (42.2)
Choroidal neovascularization (%) 16 (7.8)
doi: 10.1371/journal.pone.0072892.t001
IL23R and STAT4 Genetic Variants in Uveitis
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STAT4 SNPs (rs3821236 and rs7574865), influencing levels of
the protein [23,24,25]. Additionally, two IL23R polymorphisms
were analyzed; rs7517847, strongly associated with Crohn’s
disease and whose association seems to be independent on
rs11209026 [16], and, rs1495965, previously associated with
BD by GWASs [21,22]. On the other hand, two STAT4 genetic
variants, rs7574070 and rs897200, recently associated with
BD, were included in the study [26,27]. Both polymorphisms
seem to have functional consequences and are located in a
different linkage disequilibrium block from the SNPs rs3821236
and rs7574865.
Statistical Analysis
The overall statistical power of the analysis, according to
Power Calculator for Genetic Studies 2006 software (http://
www.sph.umich.edu/csg/abecasis/CaTS/), is shown in Table
S1. The genotype, allele and carrier frequencies were
compared between patients, subgroup of patients and controls
applying χ2 test and/or Fisher’s exact test. The Linux software
plink (v1.07) (http://pngu.mgh.harvard.edu/purcell/plink/) was
used to perform 2 × 2 contingency tables and χ2 test and/or
Fisher’s exact test when it was necessary. Odds ratios (OR)
and 95% confidence intervals (CI) were obtained according to
Woolf’s method. Hardy-Weinberg equilibrium (HWE) was
tested for all SNPs at significance level=0.01. P-values below
0.05 were considered as statistically significant.
Furthermore, the effect of the analyzed genetic variants was
analyzed either in isolation or in allelic combination analysis.
The allelic combination frequencies were estimated using plink
(v1.07) and Haploview (V. 4.2).
Possible interactions between genes were evaluated
following two different approaches: using logistic regression
and by analyzing the distribution of genotypes for one SNP in
cases conditioned by genotypes for the other SNP located in
different gene.
Results
Genotypic and allelic frequencies in cases and controls are
shown in Table 2. No statistically significant deviation from
Hardy-Weinberg equilibrium (P≤0.01) was observed for all the
studied SNPs in the control set and the frequencies of the
analyzed SNPs were in agreement with the data of the
HapMap project. Genotyping success rate was higher than
99% for all analyzed SNPs. In addition, randomly selected
samples were genotyped twice to verify the genotyping
accuracy and 99% of the genotypes were identical.
As shown in Table 2, when genotype, allele and carriers
frequencies for the analyzed STAT4 and IL23R SNPs were
compared between non-anterior uveitis patients and controls,
no association with the global disease susceptibility was
observed for any of the analyzed polymorphisms. Similarly,
when we compared the different subgroups of non-anterior
uveitis patients stratified according to the different clinical
features showed in Table 1 no statistically significant
differences were detected (data not shown).
On the other hand, the allelic combination analysis of the
studied polymorphisms located within the IL23R locus as well
as within the STAT4 gene did not provide further information
(data not shown).
Furthermore, since STAT4 and IL23R are molecules of the
same pathway, we decided to study the possible interaction
between the analyzed IL23R and STAT4 genetic variants;
Table 2. Genotype and minor allele frequencies of IL23R and STAT4 genetic variants in uveitis patients and healthy
controls.
    Genotype, N (%)   Allele test
SNP 1/2 Subgroup (n) 1/1 1/2 2/2 MAF (%) P -value* OR [CI 95%]**
IL23R         
rs7517847 G/T Controls (n=1547) 267 (17.26) 732 (47.32) 548 (35.42) 40.92   
  Non anterior Uveitis (n=206) 41 (19.90) 94 (45.63) 71 (34.47) 42.72 0.49 1.08 (0.87-1.33)
rs11209026 A/G Controls (n=1547) 8 (0.52) 211 (13.64) 1328 (85.84) 7.34   
  Non anterior Uveitis (n=206) 0 (0.00) 24 (11.65) 182 (88.35) 5.83 0.26 0.78 (0.51-1.21)
rs1495965 C/T Controls (n=1547) 326 (21.07) 738 (47.71) 483 (31.22) 44.93   
  Non anterior Uveitis (n=206) 44 (21.36) 90 (43.69) 72 (34.95) 43.20 0.51 0.93 (0.76-1.15)
STAT4         
rs3821236 A/G Controls (n=1547) 65 (4.20) 504 (32.58) 978 (63.22) 20.49   
  Non anterior Uveitis (n=206) 10 (4.85) 72 (34.95) 124 (60.19) 22.33 0.39 1.12 (0.87-1.43)
rs7574865 T/G Controls (n=1547) 72 (4.65) 533 (34.45) 942 (60.89) 21.88   
  Non anterior Uveitis (n=206) 8 (3.88) 79 (38.35) 119 (57.77) 23.06 0.59 1.07 (0.84-1.37)
rs7574070 A/C Controls (n=1547) 247 (15.97) 754 (48.74) 546 (35.29) 40.34   
  Non anterior Uveitis (n=203) 29 (14.29) 94 (46.31) 80 (39.41) 37.44 0.26 0.89 (0.72-1.10)
rs897200 T/C Controls (n=1547) 277 (17.91) 759 (49.06) 511 (33.03) 42.44   
  Non anterior Uveitis (n=205) 33 (16.10) 95 (46.34) 77 (37.56) 39.27 0.22 0.88 (0.71-1.08)
*All P-values have been calculated for the allelic model; **Odds ratio for the minor allele.
doi: 10.1371/journal.pone.0072892.t002
IL23R and STAT4 Genetic Variants in Uveitis
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however, no interaction between them was observed (data not
shown).
Discussion
No large-scale genome-wide association studies in uveitis
have been published to date, and only few genetic studies,
focused mainly on anterior uveitis, have been conducted to
identify the uveitis genetic component [9,10,11]. Indeed, only
some HLA alleles have been strongly associated with uveitis
predisposition [5,6,7,8], and genetic factors outside HLA region
influencing uveitis susceptibility remain unknown.
Autoimmune uveitis pathogenesis seems to be mainly
mediated by a T cell-driven cellular immune response [29].
Uveitis condition was traditionally considered as a Th1
mediated trait [30]; however, cumulating knowledge suggests
that IL-23, rather than IL-12, is necessary for experimental
autoimmune uveitis (EAU) induction [31]. Indeed, Th17 cells,
whose development in human is mainly induced in response to
IL-23 and IL-1β [14], release interleukin-17A that exhibits
potent proinflammatory properties in animal models of
autoimmunity, including EAU [32]. In this IL-23/IL-17 axis,
STAT4 is required for the signal transduction of IL-23 and,
consequently is involved in the development of Th17 cells [33].
Considering the shared genetic component among the
different immune-mediated diseases, including the autoimmune
uveitis [12,13,28], and the key role that Th17 responses play in
the uveitis pathogenesis, we speculated that STAT4 and
IL23R, two general autoimmunity loci, may contribute to the
non-anterior uveitis susceptibility.
However, our results evidenced no association of any
analyzed STAT4 and IL23R genetic variants with either the
non-anterior uveitis or with the studied clinical subphenotypes.
Regarding IL23R, the statistical power of our study to detect
the described odds ratios in previous GWASs on different
autoimmune diseases [16,34,35] was higher than 80%,
considering the strong effect sizes observed in those studies
for the analyzed IL23R variants (Table 3). It could be
speculated that the effect size of the analyzed IL23R
polymorphisms was similar in non-anterior uveitis than in other
autoimmune diseases. In this case, it is not likely that the lack
of association was due to a type II error. Likewise, based on
the statistical power of our study, an effect of the STAT4
rs897200 and rs7574070 genetic variants similar to that
described for BD [26,27] could be discarded in non-anterior
uveitis (Table 3). In relation to the STAT4 rs3821236 and
rs7574865 polymorphisms, there was a higher heterogeneity in
the reported ORs [36,37,38,39,40] (Table 3), with some
autoimmune diseases showing considerably stronger signals
than others (e.g. OR > 1.40 for SLE and 1.16 for RA).
Therefore, no definitive conclusions on these STAT4 variants
can be drawn.
On the other hand, associations of these IL23R and STAT4
polymorphisms with systemic autoimmune diseases involving
uveitis, such as Behçet’s disease, Vogt-Koyanagi-Harada
disease or sarcoidosis, have been described in Asian
populations [21,22,26,27,41,42,43,44] but not in Europeans.
The allele frequencies of controls in our study are similar to
those described in Asian populations. Therefore, the lack of
association of these polymorphisms with non-anterior uveitis in
the Spanish population may be due to a differential genetic
background of this disease among ethnicities rather than
differences in allele frequencies. Hence, these genes may not
be uveitis risk factors in populations of European ancestry.
In conclusion, our data do not support a relevant role of
IL23R and STAT4 polymorphisms in the genetic susceptibility
to develop non-anterior uveitis. As limitation, our study
presents a moderate statistical power due to the low
prevalence of endogenous non-anterior uveitis in Caucasian
population. Hence, a possible weak effect of the studied
variants in disease predisposition or phenotype expression
may not be discarded and, hence, additional studies in larger
independent cohorts would be desirable.
Supporting Information
Table S1.  Overall statistical power of the study for each
analyzed IL23R and STAT4 genetic variant at the 5%
significance level.
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